Page last updated: 2024-11-04

sevoflurane and Neurodegenerative Diseases

sevoflurane has been researched along with Neurodegenerative Diseases in 7 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research Excerpts

ExcerptRelevanceReference
" To investigate mechanisms by which early life anesthesia exposure could induce long-term neuronal dysfunction, we exposed rats to 1 minimum alveolar concentration sevoflurane at 7 days of life."4.02Singular and short-term anesthesia exposure in the developing brain induces persistent neuronal changes consistent with chronic neurodegenerative disease. ( Hogarth, K; Maynes, JT; Stratmann, G; Vanama, RB, 2021)
"Sevoflurane treatment decreased microglia activation by suppressing NF-kB and MAPK signaling pathways."1.51Effect of sevoflurane treatment on microglia activation, NF-kB and MAPK activities. ( Shi, J; Yu, X; Zhang, F, 2019)
"Sevoflurane is a volatile anesthetic that is frequently used for pediatric anesthesia."1.43Neuroprotective effects of caffeic acid phenethyl ester against sevoflurane‑induced neuronal degeneration in the hippocampus of neonatal rats involve MAPK and PI3K/Akt signaling pathways. ( Han, YZ; Tang, ZJ; Wang, LY, 2016)
"Our asphyxia cardiac arrest (ACA) rat model is well established."1.43Anesthesia specific differences in a cardio-pulmonary resuscitation rat model; halothane versus sevoflurane. ( Ebmeyer, U; Esser, T; Keilhoff, G, 2016)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Zheng, D1
Wang, H1
Zhou, Y1
Chen, Y1
Chen, G1
Yu, X1
Zhang, F1
Shi, J1
Qu, Y1
Li, H1
Shi, C1
Qian, M1
Yang, N1
Wang, L1
Gao, X1
Ni, C1
Hogarth, K1
Vanama, RB1
Stratmann, G1
Maynes, JT1
Lee, JR1
Lin, EP1
Hofacer, RD1
Upton, B1
Lee, SY1
Ewing, L1
Joseph, B1
Loepke, AW1
Wang, LY1
Tang, ZJ1
Han, YZ1
Esser, T1
Keilhoff, G1
Ebmeyer, U1

Other Studies

7 other studies available for sevoflurane and Neurodegenerative Diseases

ArticleYear
Ac-YVAD-cmk ameliorated sevoflurane-induced cognitive dysfunction and revised mitophagy impairment.
    PloS one, 2023, Volume: 18, Issue:1

    Topics: Animals; Caspase 1; Cognitive Dysfunction; Inflammasomes; Interleukin-18; Mice; Mitophagy; Neurodege

2023
Effect of sevoflurane treatment on microglia activation, NF-kB and MAPK activities.
    Immunobiology, 2019, Volume: 224, Issue:5

    Topics: Animals; Brain; Cell Movement; Cells, Cultured; Cytokines; Inflammation Mediators; Lipopolysaccharid

2019
lncRNAs Are Involved in Sevoflurane Anesthesia-Related Brain Function Modulation through Affecting Mitochondrial Function and Aging Process.
    BioMed research international, 2020, Volume: 2020

    Topics: Aging; Anesthesia; Anesthetics; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cognition Disorde

2020
Singular and short-term anesthesia exposure in the developing brain induces persistent neuronal changes consistent with chronic neurodegenerative disease.
    Scientific reports, 2021, 03-11, Volume: 11, Issue:1

    Topics: Anesthesia; Animals; Animals, Newborn; Apoptosis; Autophagosomes; Brain; Chronic Disease; Homeostasi

2021
Alternative technique or mitigating strategy for sevoflurane-induced neurodegeneration: a randomized controlled dose-escalation study of dexmedetomidine in neonatal rats.
    British journal of anaesthesia, 2017, Sep-01, Volume: 119, Issue:3

    Topics: Anesthetics, Inhalation; Animals; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationshi

2017
Neuroprotective effects of caffeic acid phenethyl ester against sevoflurane‑induced neuronal degeneration in the hippocampus of neonatal rats involve MAPK and PI3K/Akt signaling pathways.
    Molecular medicine reports, 2016, Volume: 14, Issue:4

    Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Caffeic Acids; Female; Hippocampus; MAP Kinase S

2016
Anesthesia specific differences in a cardio-pulmonary resuscitation rat model; halothane versus sevoflurane.
    Brain research, 2016, 12-01, Volume: 1652

    Topics: Anesthetics, Inhalation; Animals; Asphyxia; CA1 Region, Hippocampal; Cardiopulmonary Resuscitation;

2016